2023
DOI: 10.1016/j.eclinm.2023.102034
|View full text |Cite
|
Sign up to set email alerts
|

Trends in the burden and determinants of hypertensive heart disease in the Eastern Mediterranean region, 1990–2019: an analysis of the Global Burden of Disease Study 2019

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 35 publications
0
7
0
Order By: Relevance
“…Interventions may enhance cardiovascular health and reduce the risks of high blood pressure by focusing on endothelial dysfunction [19]. [4]…”
Section: Dysfunction Of the Endotheliummentioning
confidence: 99%
See 1 more Smart Citation
“…Interventions may enhance cardiovascular health and reduce the risks of high blood pressure by focusing on endothelial dysfunction [19]. [4]…”
Section: Dysfunction Of the Endotheliummentioning
confidence: 99%
“…It is also helpful to understand how these indicators relate to blood pressure so as better comprehend the causes of hypertension. [4] Moreover, HHD is one of the leading causes of death and disability round the globe. In fact it develops due to untreated hypertension.…”
Section: Introductionmentioning
confidence: 99%
“…This disease is considered the rst priority in cardiovascular research in Iran (9). Moreover, HTN enormously has in uenced the economy around the world, especially in Middle East countries enormously (10,11).…”
Section: Introductionmentioning
confidence: 99%
“…Current evidence suggests that more than 1.5 billion people will bear the health and economic burden of hypertension in the coming years, which predicts that a range of diseases attributable to hypertension will also be a constant threat to public health in everyday life, particularly cardiovascular disease (CVD) and chronic kidney disease (CKD) (2). Multiple studies from 2016 to 2023 have shown that the global disease burden of CVD, CKD, and cardiovascular death due to hypertension continues to increase, with a study from southwestern China predicting that a 25% reduction in the prevalence of high systolic blood pressure (SBP) by 2030 would result in a reduction of 26,200 and 8,000 cases of CVD and CKD, respectively, and a reduction of cardiovascular mortality and CKD mortality by 32.8 and 16%, respectively (3)(4)(5)(6)(7)(8). These data suggest that the burden of a series of diseases caused by hypertension remains very heavy, and the formulation of high-quality prevention, management and treatment strategies for hypertension often fail to address the underlying problem, so early screening and intervention of controllable risk factors for hypertension from the source is particularly important for reducing the incidence, prevalence and mortality of hypertension and related diseases.…”
Section: Introductionmentioning
confidence: 99%